JSPR
Price
$18.83
Change
-$0.01 (-0.05%)
Updated
Sep 27 closing price
KYMR
Price
$48.69
Change
-$0.78 (-1.58%)
Updated
Sep 27 closing price
39 days until earnings call
Ad is loading...

JSPR vs KYMR

Header iconJSPR vs KYMR Comparison
Open Charts JSPR vs KYMRBanner chart's image
Jasper Therapeutics
Price$18.83
Change-$0.01 (-0.05%)
Volume$116.66K
CapitalizationN/A
Kymera Therapeutics
Price$48.69
Change-$0.78 (-1.58%)
Volume$243.19K
CapitalizationN/A
View a ticker or compare two or three
JSPR vs KYMR Comparison Chart
Loading...
JSPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
JSPR vs. KYMR commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSPR is a Hold and KYMR is a Hold.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (JSPR: $19.18 vs. KYMR: $46.32)
Brand notoriety: JSPR and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JSPR: 136% vs. KYMR: 54%
Market capitalization -- JSPR: $284.43M vs. KYMR: $3.14B
JSPR [@Biotechnology] is valued at $284.43M. KYMR’s [@Biotechnology] market capitalization is $3.14B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.37B to $0. The average market capitalization across the [@Biotechnology] industry is $3.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JSPR’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • JSPR’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, JSPR is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JSPR’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 2 bullish TA indicator(s).

  • JSPR’s TA Score: 5 bullish, 2 bearish.
  • KYMR’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, JSPR is a better buy in the short-term than KYMR.

Price Growth

JSPR (@Biotechnology) experienced а -5.28% price change this week, while KYMR (@Biotechnology) price change was -5.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.80%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was -8.06%.

Reported Earning Dates

JSPR is expected to report earnings on May 10, 2024.

KYMR is expected to report earnings on Nov 07, 2024.

Industries' Descriptions

@Biotechnology (+3.80% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.15B) has a higher market cap than JSPR($284M). JSPR YTD gains are higher at: 143.093 vs. KYMR (81.932).
JSPRKYMRJSPR / KYMR
Capitalization284M3.15B9%
EBITDAN/AN/A-
Gain YTD143.09381.932175%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt2.55MN/A-
TECHNICAL ANALYSIS
Technical Analysis
JSPRKYMR
RSI
ODDS (%)
Bullish Trend about 1 month ago
0%
N/A
Stochastic
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend about 2 months ago
0%
Bearish Trend about 2 months ago
0%
BollingerBands
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Aroon
ODDS (%)
Bearish Trend about 1 month ago
0%
N/A
View a ticker or compare two or three
Ad is loading...
JSPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with OMGA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then OMGA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-12.02%
OMGA - JSPR
43%
Loosely correlated
-6.80%
ATXI - JSPR
30%
Poorly correlated
+9.84%
KYMR - JSPR
29%
Poorly correlated
-4.22%
KROS - JSPR
27%
Poorly correlated
+5.38%
IMNM - JSPR
26%
Poorly correlated
-7.51%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with RXRX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-4.22%
RXRX - KYMR
51%
Loosely correlated
-16.62%
KROS - KYMR
49%
Loosely correlated
+5.38%
CRSP - KYMR
49%
Loosely correlated
-4.61%
EDIT - KYMR
49%
Loosely correlated
-6.68%
NTLA - KYMR
49%
Loosely correlated
-3.65%
More